AMLO allocates 180 million pesos for the development of the Patria vaccine against covid

President Andrés Manuel López Obrador (AMLO) reported that 180 million pesos were allocated for the development of the homeland vaccine against covid, What does the National Council of Science and Technology (Conacyt).

We recommend you: Mexico has an agreement with Cuba to acquire its covid Abdala vaccine: AMLO

“Research is already being carried out in Mexico -and the Patria vaccine is going very well-, so we are going to have our vaccine, we are working towards that. Conacyt has all the support, the investigation team, we have just authorized 180 million pesos to support the investigation “, reported AMLO at his morning lecture.

Moments before, López Obrador announced that his government will challenge the court order that issued a federal judge to vaccinate against the covid to all kids in Mexico.

What technology will the Homeland vaccine?

The Patria vaccine is based on state-of-the-art technology created in New York and Texas, USA; To produce it successfully, a state-of-the-art technological infrastructure and highly trained human teams are needed.

“It would be a second generation of vaccines against coronavirus”, Constantino III López Magaña, doctor in Biomedical Sciences, UNAM.

The vaccine Homeland will use a virus that does not infect humans but birds, causing them a respiratory disease; It is called Newcastle virus and it is modified so that on its surface it carries the spike protein of the SARS-CoV-2 virus.

The spike protein is, in turn, modified with a called protein Hexapro, which gives it stability and makes it generate more effective antibodies.

It is virus can be easily replicated in a chicken egg, which makes it cheaper to produce the vaccine, already packaged, it is applied either nasally or intramuscularly.

“This stabilization that the vaccine generates needs to be in a shape like a tulip; when the virus invades, the spicule protein becomes like a spear ”, Constantino III López Magaña, PhD in Biomedical Sciences, UNAM.

This technology was developed at the Icahn School of Medicine at Mount Sinai, in New York and protein Hexapro was designed by University of Texas.

“It uses a production method very similar or identical to that of other vaccines that are being used frequently in the world, they are vectors that have a great capacity to induce a strong immunogenic response, this is what we want to test now”, Adolfo GarcÍa Sastre, director from the Institute for Global Health and Emerging Pathogens, Mount Sinai, NY.

Next, we share the complete video of AMLO’s morning conference.

With information from Noticieros Televisa.

RAMG

<!– –>

Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more

Leave a Reply